Eli Lilly’s stock has hit a 52-week low at $697.35, nosediving over 10% this past week, which has investors holding their ...
The Killeen Independent School District on April 7 announced Dr. Bobbie Reeders has been appointed to serve as interim ...
We, like so many others, have been forced to take steps to extend our cash runway,” said Tango’s CEO, citing the “extremely challenging financial markets.” ...
Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...
As demand soared for weight-loss drugs, price signals worked.
The Trump administration has decided not to go forward with a proposal for Medicare and Medicaid to cover high-demand obesity ...
Explore more
The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.
The Trump administration did away with a Biden-era proposal to allow Medicare to start paying for weight loss drugs such as ...
Novo Nordisk Considers Early Launch of Weight-Loss Jab Wegovy in India, Reuters Says, Citing Sources
--Novo Nordisk is considering launching its weight loss injection Wegovy in India sooner than planned to better challenge U.S. rival Eli Lilly, Reuters reports, citing unnamed sources.
A man was sentenced to prison after collecting thousands of files of child pornography and disturbing content on the internet ...
Ahead of Mother’s Day, the Salvation Army is partnering with Two Men and a Truck for the Movers for Moms campaign. This ...
Eli Lilly & Co.’s shares fell Monday morning after the Trump administration spiked a plan late last week to pay for obesity drugs for Medicare patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results